Immuneering Launches Pancreatic Cancer Advisory Board
Go back to Immuneering Launches Pancreatic Cancer Advisory Board| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 4.51 +0.05 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.46 | 52 Week High | $0.04 | |||
| Open | $4.53 | 52 Week Low | $0.00 | |||
| Day High | $4.57 | P/E | N/A | |||
| Day Low | $4.43 | EPS | $-0.09 | |||
| Volume | 720,266 | |||||

